Urothelial tumors of the upper & lower urinary tracts MCQ Question with Answer

Urothelial tumors of the upper & lower urinary tracts MCQ with detailed explanation for interview, entrance and competitive exams. Explanation are given for understanding.

Download Urothelial tumors of the upper & lower urinary tracts MCQ Question Answer PDF

Question No : 8
Concerning upper tract urothelial tumors, what is the single most important predictor of outcome?

tumor stage
tumor grade
lymphovascular invasion
lymph node spread

Question No : 9
Which of the following statements concerning lymphatic drainage of the male urethra is true?

the anterior urethra drains into the inguinal and pelvic nodes
the posterior urethra drains into the pelvic nodes
the proximal two-thirds drain into the external and internal iliac nodes
the distal one-third drains into the obturator nodes

Question No : 10
Partial penectomy for urethral cancer is indicated in:

infiltrative proximal penile urethral carcinomas
infiltrative distal penile urethral carcinomas
recurrent proximal penile urethral carcinoma after laser resection
T3/N2/M0 at bulbar urethra

Question No : 11
The treatment of nonmuscle-invasive bladder cancer begins with:

single intravesical chemotherapy
intravesical BCG vaccine
multiple bladder biopsies

Question No : 12
What is the most common sarcoma of the bladder?


Question No : 13
The treatment of T2/Nx/M0 prostatic urethral cancer is:

en bloc resection involving total penectomy, cystoprostatectomy, resection of the pubic rami and urogenital diaphragm, with pelvic lymphadenectomy. In addition, creating a urinary diversion.
total penectomy involving removal of the penis, urethra, and penile root
partial penectomy involving excision of the malignant lesion with 2-cm margins
transurethral resection or fulguration

Question No : 14
What is the ideal vesical tumor patient for bladder preservation?

patients with carcinoma in situ
patients with completely resected solitary tumor
patients with preserved kidney and liver functions after 2 courses of BCG
patients with leiomyosarcoma